Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Otgonchimeg Rentsendorj

Center for Biologics Evaluation and Research- FDA, USA

Title: Altered epigenetic regulation of renal antioxidant enzyme systems in guinea pigs infused with polymerized cell-free hemoglobin

Biography

Biography: Otgonchimeg Rentsendorj

Abstract

Polymerized cell-free hemoglobins are being developed as oxygen and plasma volume-expanding therapeutics though their potential to promote oxidative tissue injury has raised safety concerns. Using a guinea pig exchange transfusion model, we explored oxidant mechanisms of polymerized bovine hemoglobin (HbG) in renal injury. Several renal injury markers including oxidative stress and inflammation markers were targeted. HbG infusion increased tubular injury markers including neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury marker-1 and reduced the transcription of glomerular filtration barrier components including podocin, and nephrin. Increased renal heme oxygensase-1 (HO-1) and decreased enzymatic antioxidants including SOD isoforms 1-3, GPx1, GPx3, GPx4, and CAT were also detected at the mRNA, protein, and activity levels. Furthermore, DNA methylation analyses identified CpG hypermethylation in the gene promoters for all enzymatic antioxidants that we studied suggested an epigenetic-based mechanism underlying the observed gene repression. HbG also induced oxidative stress as evidenced by increased renal lipid peroxidation end-products and 4-HNE immunostaining, which could be the result of the depleted antioxidant defenses and/or serve as a trigger for increased DNA methylation. Together, these findings provide evidence that the renal exposure to HbG suppresses the function of major antioxidant defense systems which may have relevant implications for understanding the safety of hemoglobin-based products and may serve as sensitive and specific biomarkers in kidney injury.